Depression studies

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown

Showing 2,041-2,052 of 7,264

CompletedEUCTR 2004-000167-95

Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany

DepressionHistorical research record

Countries: Germany, Italy, Sweden
Sponsor: Eli Lilly and Company Limited

View study

CompletedEUCTR 2010-023576-10

Early effect of agomelatine on general interest in outpatients with Major Depressive Disorder. A 12-week, randomized, double-blind, multicentre study with parallel groups: agomelatine (25mg/day giv...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Romania

DepressionHistorical research record

Countries: Romania
Sponsor: Institut de Recherches Internationales Servier

View study

CompletedEUCTR 2010-024191-25

Effects of agomelatine (25 to 50 mg/day) on circadian rhythms in patients with Major Depressive Disorder. An exploratory 6-week open, flexible dose, international multicentre, non comparative study.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria

DepressionHistorical research record

Countries: Austria, Germany
Sponsor: Institut de Recherches Internationales Servier

View study

CompletedEUCTR 2007-003312-65

Efficacy and safety of 2 doses of S 90098 (1 and 2mg/day), sublingual formulation for 8 weeks in out-patients with Major Depressive Disorder. An 8-week randomised, double-blind, fixed dose, interna...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic

DepressionHistorical research record

Countries: France, Czechia, Estonia, + 2 others
Sponsor: Institut de Recherches Internationales Servier

View study

CompletedEUCTR 2009-011238-84

Efficacy and safety of 3 dose regimens of agomelatine (10, 25, 25-50 mg) versus placebo given once a day for 6 weeks in out-patients suffering from moderate to severe Major Depressive Disorder. A 6...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria

DepressionHistorical research record

Countries: Bulgaria, Finland, Slovakia
Sponsor: Institut de Recherches Internationales Servier

View study

CompletedEUCTR 2009-014045-92

Efficacy and safety of 3 doses (0.25, 0.5 and 1mg/day) of agomelatine sublingual administration over an 8-week treatment period, in out-patients with Major Depressive Disorder. An 8-week randomis...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic

DepressionHistorical research record

Countries: France, Czechia, Estonia, + 2 others
Sponsor: Institut de Recherches Internationales Servier

View study

CompletedEUCTR 2015-003867-13

Efficacy and safety of S 47445 versus placebo as adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to antidepressant therapy. A randomised, double-blind, pla...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria

DepressionHistorical research record

Countries: Bulgaria, Czechia, Finland, + 2 others
Sponsor: Institut de Recherches internationales Servier

View study

CompletedEUCTR 2012-005612-26

Efficacy and safety of tianeptine oral administration (25 to 50 mg/day) in elderly patients suffering from Major Depressive Disorder. A 8-week, randomized, double-blind, flexible-dose, parallel gr...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria

DepressionHistorical research record

Countries: Bulgaria, Estonia, Finland, + 1 other
Sponsor: Institut de Recherches Internationales Servier

View study

CompletedEUCTR 2012-004062-17

Efficacy of add-on pregabalin in the treatment of Generalized Anxiety Disorder comorbid with Major Depressive Disorder: a double-blind placebo-controlled study.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Greece

Depression, AnxietyHistorical research record

Countries: Greece
Sponsor: Aristotle University of Thessaloniki

View study

CompletedEUCTR 2004-004009-10

Efficacy of agomelatine (25 mg/day with potential adjustment to 50 mg) given orally on rest/activity circadian rhythms in outpatients with Major Depressive Disorder. A randomized, double-blind inte...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria

DepressionHistorical research record

Countries: Austria, Germany, Italy, + 1 other
Sponsor: Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only)

View study

CompletedEUCTR 2006-006540-54

Efficacy of agomelatine (25 to 50 mg/day) given orally on improvement of subjective sleep in patients with Major Depressive Disorder. A randomised, double-blind, flexible-dose international multice...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France

DepressionHistorical research record

Countries: France, United Kingdom
Sponsor: Institut de Recherches Internationales Servier

View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.